Lawyers for Moderna have appeared before the Coroners Court of Victoria for a hearing into the death of Natalie Boyce, a 21-year-old law and commerce student who died from myocarditis after taking the Moderna COVID-19 vaccine.
The Coroners Court is currently investigating whether Ms. Boyce’s death was caused by the Moderna COVID-19 vaccine.
On April 17, the court was told that Ms. Boyce received her third vaccine, which was the Moderna vaccine, on Feb. 18, 2022.
Around one week later, she went to a general practitioner (GP) after experiencing vomiting for five days, along with aching pain and fainting at one point.
In the ensuing weeks, Ms. Boyce went to a hospital and a medical centre as her symptoms persisted.
Then, on March 5, she attended Mulgrave Private Hospital after suffering from chest pain and shortness of breath. She was then transferred to The Alfred, where she was diagnosed with fulminant myocarditis, a severe cardiac inflammation disease that is often fatal.
Ms. Boyce’s condition deteriorated after undergoing surgery to remove a blood clot. She later suffered a heart attack during an MRI.
What the Autopsy Report Revealed
A post-mortem on Ms. Boyce found that she died from an acute myocarditis infarction.“[G]iven the close proximity in time due to vaccine, a vaccine-related myocarditis cannot be excluded,” the autopsy report said.
However, the report also said that acute myocarditis infarction could not be diagnosed post-mortem.
Meanwhile, Moderna’s cardiologist submitted a letter to the court saying that “the conclusion from the autopsy report should be accepted: that a definitive cause for Ms. Boyce’s myocarditis cannot be identified.”
This was in reference to the report by Moderna’s cardiologist, whose findings have differed from other medical evidence presented to the coroner, counsel assisting Jessika Syrjanen said.
However, Ms. Syrjanen did not detail how Moderna’s report differed from the other medical evidence concerning Ms. Boyce’s cause of death and medical management.
“I seek clarification from Moderna’s legal representatives today as to Moderna’s current position and whether that has changed,” Ms. Syrjanen said.
In response, Moderna’s lawyer, Jesse Rudd, said she could not provide instant clarification on the company’s position and has sought time to seek advice.
In February, Moderna engaged its own cardiologist to provide an expert opinion to the court, and asked for extended leave to provide a report from them.
All parties have been given eight weeks to read through Moderna’s report and consider their positions.
The case will return to court on July 17.
